RELAPSED LEUKEMIA
Clinical trials for RELAPSED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stubborn leukemia: three-drug combo enters human trials
Disease control Recruiting nowThis study tests whether adding a new drug called roginolisib to two standard drugs (venetoclax and rituximab) is safe and works better for people with CLL that has come back or not responded to prior treatments. About 64 adults who have already tried at least two other therapies…
Matched conditions: RELAPSED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
New hope for hard-to-treat leukemia: early trial combines chemo with donor cells before transplant
Disease control Recruiting nowThis early-phase study is for people with relapsed or refractory leukemia, meaning their cancer has returned or not responded to standard treatments. The approach combines chemotherapy with an infusion of immune cells from a partially matched donor, given as a bridge to a stem ce…
Matched conditions: RELAPSED LEUKEMIA
Phase: PHASE1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated May 19, 2026 11:46 UTC